Carmichael Hill & Associates, Inc. Pfizer Inc Transaction History
Carmichael Hill & Associates, Inc.
- $279 Million
- Q3 2024
A detailed history of Carmichael Hill & Associates, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Carmichael Hill & Associates, Inc. holds 19,850 shares of PFE stock, worth $516,497. This represents 0.21% of its overall portfolio holdings.
Number of Shares
19,850
Previous 19,631
1.12%
Holding current value
$516,497
Previous $549,000
4.55%
% of portfolio
0.21%
Previous 0.22%
Shares
28 transactions
Others Institutions Holding PFE
# of Institutions
3,271Shares Held
3.63BCall Options Held
74.3MPut Options Held
107M-
Vanguard Group Inc Valley Forge, PA516MShares$13.4 Billion0.27% of portfolio
-
Black Rock Inc. New York, NY424MShares$11 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.56 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA164MShares$4.26 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA130MShares$3.39 Billion0.73% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $146B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...